Mentored, three-year award supporting early-career clinical investigators to establish an independent, patient-oriented clinical cancer research program (clinical and/or translational involving human subjects; not primarily in vitro or animal).
Eligibility Criteria:
-
Physician (MD, DO, or international equivalent).
-
In years 1–4 of a full-time primary clinical faculty appointment at an academic institution.
-
Valid medical license in the research country.
-
Track record showing readiness for independent, investigator-initiated clinical research.
-
ASCO member (or membership application submitted with CDA).
-
Commit ≥50% total effort to research during the award period.
-
Mentor at the sponsoring institution (if mentor not an ASCO member, include supporting letter from an ASCO member).
-
In good standing on any prior Conquer Cancer grants; no overlap with other awards (must disclose).
-
Not a PI on large project grants (e.g., R01 or international equivalent).
Funding Details:
-
Total: USD 200,000 over 3 years (supports personnel/research expenses and travel to ASCO Grants & Awards Ceremony).
-
2026 dedicated areas include (not limited to): Palliative and Supportive Care in Oncology; Breast Cancers.
Deadline:
- Application Deadline: October 9, 2025.
- Award Term: July 1, 2026 – June 30, 2029.
Where To Go For Further Information: